An updated approach to healthcare-associated meningitis
- 6 February 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 12 (3) , 333-342
Abstract
Among hospital-associated infections, healthcare-associated central nervous system infections are quite important because of high morbidity and mortality rates. The causative agents of healthcare-associated meningitis differ according to the status of immune systems and underlying diseases. The most frequent agents are Gram-negative bacilli (Pseudomonas spp., Acinetobacter spp., Escherichia coli and Klebsiella pneumoniae) and Gram-positive cocci (Staphylococcus aureus and coagulase-negative staphylococci). There are currently several problems in the treatment strategies of healthcare-associated meningitis due to a globally increasing resistance problem. Strategies targeting multidrug-resistant pathogens are especially limited. This review focuses on healthcare-associated meningitis and the current treatment strategies with a particular focus on methicillin-resistant Staphylococcus aureus (MRSA) meningitis.Keywords
This publication has 69 references indexed in Scilit:
- Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus MeningitisSurgical Infections, 2013
- Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul StudyAntimicrobial Agents and Chemotherapy, 2012
- Methicillin-Resistant Staphylococcus aureus Meningitis in AdultsMedicine, 2012
- The Causes and Treatment Outcomes of 91 Patients with Adult Nosocomial MeningitisThe Korean Journal of Internal Medicine, 2012
- Efficacy and safety of tigecycline: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2011
- Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: A series of 17 casesScandinavian Journal of Infectious Diseases, 2011
- Widespread Emergence of Multidrug Resistant Pseudomonas aeruginosa Isolated from CSF SamplesIndian Journal of Microbiology, 2011
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial MeningitisClinical Microbiology Reviews, 2010
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2010
- Management of meningitis due to antibiotic-resistant Acinetobacter speciesThe Lancet Infectious Diseases, 2009